OptimizeRx Corp
OPRX
Market Cap$185.83M
Close$
$-2.13
121.4% downside
Current Fair Value
121.4% downsideOvervalued by 121.4% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $185.83 Million |
|---|---|
| Enterprise Value | $175.62 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-1.1 |
| Beta | 1.18 |
| Outstanding Shares | 18,418,519 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -9.21 |
|---|---|
| PEG | -4.21 |
| Price to Sales | 2.48 |
| Price to Book Ratio | 1.65 |
| Enterprise Value to Revenue | 1.99 |
| Enterprise Value to EBIT | -5.58 |
| Enterprise Value to Net Income | -8 |
| Total Debt to Enterprise | 0.02 |
| Debt to Equity | 0.03 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About OptimizeRx Corp
OptimizeRx is a digital health company that provides communications solutions for life science companies, physicians and patients. Connecting over half of healthcare providers in the U.S. and millions of patients through a proprietary ne...